Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490763 · ClinicalTrials.gov registry record
Active Surveillance in Prostate Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 1,139
- Enrollment target
NCT00490763: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00490763 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,139 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490763 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 1,139 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if men who have a type of prostate cancer that has been classified as "low risk" can safely not be treated for the disease. Doctors want to know if patients with "low risk" cancer can avoid or postpone therapy and the related side effects and still live as long as patients who immediately receive therapy. This is an investigational study. There are no medications used in this trial. About 1,000 patients will take part in this study. All will be enrolled at MD Anderson.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,139 participants |
| Start Date | 2006-02-13 |
| Est. Completion | 2021-09-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00490763
The ClinicalTrials.gov registry entry for NCT00490763 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT00490763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00490763 about?
NCT00490763 is a clinical study titled "Active Surveillance in Prostate Cancer". The goal of this clinical research study is to find out if men who have a type of prostate cancer that has been classified as "low risk" can safely not be treated for the disease. Doctors want to know if patients with "low risk" cancer can avoid or postpone therapy and the related side effects and s...
What is the current status of trial NCT00490763?
This trial is currently completed. The enrollment target is 1,139 participants. The study started on 2006-02-13. Estimated completion is 2021-09-06.
What interventions are being tested in trial NCT00490763?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00490763?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.